Status:
COMPLETED
Treatment of Smoking Lapses and Relapses
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Many smokers who try to stop smoking with nicotine medications (NM) such as gum, lozenge and patch, go back to smoking (i.e., a slip or lapse). Currently, labeling on many NM products tells smokers wh...
Detailed Description
Objectives: To test our hypothesis that among the subset of the 770 enrolled participants who quit smoking and then lapsed while using the nicotine patch, those randomized to continue the patch post-...
Eligibility Criteria
Inclusion
- at least 18 years old
- daily smoker of 10 or more cigarettes per day for at least 1 year
- state they plan to probably or definitely quit smoking in the next month
- have a home or cell phone
- willing to use nicotine patch
- good command of written and spoken English
- weigh at least 100 pounds
- US citizen or permanent resident alien
Exclusion
- use of non-cigarette tobacco in the last month
- use of a smoking cessation medication or smoking cessation counseling in the last month
- medical contraindication to use of patch
- other person in household already in our study
- previously a participant in the study
- currently pregnant or breast feeding
- plan to become pregnant in the next 6 months
- regularly works the overnight shift
- use of electronic cigarettes in the last month
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
701 Patients enrolled
Trial Details
Trial ID
NCT01807871
Start Date
March 1 2013
End Date
February 1 2016
Last Update
October 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont
Burlington, Vermont, United States, 05401